Sedana Medical's CEO Christer Ahlberg is leaving the company
Sedana Medical AB (publ) (SEDANA: FN Stockholm) today announced that Christer Ahlberg has informed the board of directors of Sedana Medical that he is resigning as CEO to become CEO of Cinclus Pharma AB. Christer Ahlberg will remain as CEO until the summer of 2021 and the board is today starting a process to find a replacement.“Sedana Medical is well on its way in establishing inhaled sedation as a standard treatment in intensive care. I strongly believe in that development and intend to remain a major shareholder. It has been fun and exciting years and it has been a privilege to build